期刊文献+

防线前移时不我待:中国高血压积极防控的时代已来

Moving Forward the Defense Line and Wasting No Time:The Era of Active Prevention and Control of Hypertension in China Has Come
下载PDF
导出
摘要 为全面提升高血压规范化筛查、诊断与治疗水平,中华医学会心血管病学分会、海峡两岸医药卫生交流协会高血压专业委员会、中国康复医学会心血管疾病预防与康复专业委员会联合发起并制定了《中国高血压临床实践指南》。该指南针对当前我国高血压筛查、诊断、评估和治疗领域的若干重要临床问题,充分评估目前可获得的最新高质量研究证据,给出了明确的推荐意见,倡导高血压诊治防线前移、强化降压、简化心血管病危险分层、重视继发性高血压筛查等全新理念和观点,必将促进我国高血压防治事业的进步。 To comprehensively improve the level of standardized screening,diagnosis and treatment of hypertension,the Clinical practice guidelines for the management of hypertension in China has been jointly initi-ated by Chinese Society of Cardiology,Chinese Medical Association,Hypertension Committee of Cross-Straits Medicine Exchange Association,Cardiovascular Disease Prevention and Rehabilitation Committee,and Chinese Association of Rehabilitation Medicine.This guideline addresses several important clinical problems in the field of screening,diagnosis evaluation and treatment of hypertension,fully assesses the latest high-quality clinical research evidences available,and gives clear recommendations.It also advocates the new concepts and per-spectives,such as moving forward the diagnosis and treatment of hypertension,promoting the target of blood pressure reduction,simplifying the risk stratification of cardiovascular diseases,and paying attention to the screening of sec-ondary hypertension,which will help promote the prevention and treatment of hypertension in China.
作者 娄莹 蔡军 LOU Ying;CAI Jun(Department of Cardiology,Fuwai Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,National Center for Cardiovascular Diseases,Beijing 100037,China;Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《协和医学杂志》 CSCD 北大核心 2024年第6期1238-1241,共4页 Medical Journal of Peking Union Medical College Hospital
关键词 高血压 指南 诊断与治疗 预防 hypertension guidelines diagnosis and treatment prevention
  • 相关文献

参考文献2

二级参考文献49

  • 1邢红云,徐新娟,王伟.帕罗西汀对高血压伴焦虑抑郁患者血压和心率变异性影响[J].中国现代应用药学,2009,26(S1):1188-1191. 被引量:5
  • 2戚文航,潘长玉,林善琰.我国部分地区高血压登记调查及治疗达标研究[J].中华心血管病杂志,2007,35(5):457-460. 被引量:46
  • 3Abstracts of the American Society of Hypertension 20th Annual Meeting. May 14- 18,2005, San Francisco, California, USA. Am J Hypertens, 2005, 18 ( 5 Pt 2 ) : 1 A-296A.
  • 4Ohta Y, Tsuchihashi T, Onaka U, et al. Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients. Intern Med, 2010, 49: 1483-1487.
  • 5Mancia G, Volpe R, Boros S, et, al. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens, 2004, 22:51-57.
  • 6Jackson JH, Sobolski J, Krienke R, et al. Blood pressure control and pharmacotherapy patterns in the United States before and after the release of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. J Am Board Fam Med, 2008, 21:512-521.
  • 7Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988 - 008. JAMA, 2010, 303:2043-2050.
  • 8Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm, 2006,12:239-245.
  • 9Duru OK, Vargas RB, Kermah D, et at. Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens, 2007, 20:348-353.
  • 10Bleieh SN, Cutler DM, Adams AS, et at. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ, 2007, 335:875.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部